ST GZBL and other investors establish a new company including health food production business

According to the Qichacha APP, recently, Guizhou Bailing Yongkang Biotechnology Development Co., Ltd. was established, with Zhang Yawei as the legal representative and a registered capital of 3 million yuan. The business scope includes: operation of Class III medical devices; production of health food; food production; research and development of biological pesticide technology; research and development of biological feed; cultivation of traditional Chinese medicinal herbs, etc. Qichacha's equity penetration shows that the company is jointly held by Hefei Benfang Equity Investment Partnership and Tibet Jinling Pharmaceutical Technology Development Co., Ltd. under ST Bailing